CYPHERPUNK TECHNOLOGIES INC.

CYPH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2021 FY2020
Revenue $1.5M $1.5M
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $32.2M $20.4M
SG&A Expense $10.8M $9.6M
Operating Income $-41.4M $-28.5M
Operating Margin -2,761.7% -1,902.6%
Interest Expense $41.0K $39.0K
Pretax Income $-40.6M $-27.5M
Income Tax Expense $-24.0K $-2.0K
Net Income $-40.6M $-27.5M
Net Margin -2,705.8% -1,834.3%
EPS (Basic) $-0.47 $-0.63
EPS (Diluted) $-0.47 $-0.63
Shares Outstanding (Basic) 85.8M 59.3M
Shares Outstanding (Diluted) 85.8M 59.3M
Dividends Per Share